Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
295 GBX | -1.01% | -0.34% | +4.24% |
Financials (USD)
Sales 2024 * | 691M | Sales 2025 * | 849M | Capitalization | 3.2B |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | - | EV / Sales 2024 * | 4.27 x |
Net cash position 2024 * | 256M | Net cash position 2025 * | 383M | EV / Sales 2025 * | 3.32 x |
P/E ratio 2024 * |
-29.6
x | P/E ratio 2025 * |
269
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.39% |
Latest transcript on HUTCHMED (China) Limited
1 day | -1.01% | ||
1 week | -0.34% | ||
1 month | -1.67% | ||
3 months | +22.41% | ||
6 months | +1.72% | ||
Current year | +4.24% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
CHM | Chairman | 70 | 16-07-31 |
Edith Shih
BRD | Director/Board Member | 71 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 295 | -1.01% | 233 |
24-05-30 | 298 | +1.02% | 11,836 |
24-05-29 | 295 | -1.67% | 23,206 |
24-05-28 | 300 | +1.35% | 48,204 |
24-05-24 | 296 | -2.63% | 13,827 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.24% | 3.2B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- HCM Stock